Commercial success of pharmaceutical products today depends increasingly upon understanding the needs of commercial and government payers in the highly-influential Managed Markets sector. Recognizing this paradigm shift, savvy bio-pharmaceutical companies are seeking to improve their access to payers to develop the best possible Managed Markets insights before product launch.